Matea Kovačić1, Josipa Unić1, Zrinjka Mišak2, Oleg Jadrešin2, Vlatka Konjik3,4, Sanja Kolaček1,2, Iva Hojsak5,6,7. 1. University of Zagreb School of Medicine, Zagreb, Croatia. 2. Referral Center for Pediatric Gastroenterology and Nutrition, Children's Hospital Zagreb, Klaićeva 16, 10000, Zagreb, Croatia. 3. University J.J. Strossmayer School of Medicine Osijek, Osijek, Croatia. 4. Department of Pediatrics, University Hospital Osijek, Osijek, Croatia. 5. University of Zagreb School of Medicine, Zagreb, Croatia. ivahojsak@gmail.com. 6. Referral Center for Pediatric Gastroenterology and Nutrition, Children's Hospital Zagreb, Klaićeva 16, 10000, Zagreb, Croatia. ivahojsak@gmail.com. 7. University J.J. Strossmayer School of Medicine Osijek, Osijek, Croatia. ivahojsak@gmail.com.
Abstract
BACKGROUND AND AIMS: Despite rising incidence of eosinophilic esophagitis (EoE), data on the follow-up and treatment outcomes in pediatric patients are scarce. Therefore, the aim of this study was to present data on the treatment outcomes in children diagnosed with EoE who were treated in a tertiary medical center. PATIENTS AND METHODS: A retrospective study involving patients younger than 18 years who were diagnosed with EoE in our center between January 2011 and June 2017. RESULTS: Thirty-two patients met inclusion criteria and were followed up for a mean of 3 years (range 0.5-6.8). Six months after the diagnosis, 28 (87.5%) children were still followed up; 21 (75%) were in clinical remission, including 10 (36%) who were in histological remission. After 12 months, 27 patients were still followed up; 21 (78%) achieved clinical remission, including 10 (37%) with histological remission. During follow-up, three patients developed gastroesophageal reflux disease (GERD). There was no difference in body mass index (BMI) Z score between baseline and 12 months follow-up (median - 0.3 vs - 0.3 SD, p = 0.862). CONCLUSIONS: Absence of symptoms does not indicate mucosal healing; therefore, patients should be followed up endoscopically. Additionally, despite restricted diet, nutritional status remains unaffected. Finally, patients with EoE can develop significant GERD even years after the EoE diagnosis.
BACKGROUND AND AIMS: Despite rising incidence of eosinophilic esophagitis (EoE), data on the follow-up and treatment outcomes in pediatric patients are scarce. Therefore, the aim of this study was to present data on the treatment outcomes in children diagnosed with EoE who were treated in a tertiary medical center. PATIENTS AND METHODS: A retrospective study involving patients younger than 18 years who were diagnosed with EoE in our center between January 2011 and June 2017. RESULTS: Thirty-two patients met inclusion criteria and were followed up for a mean of 3 years (range 0.5-6.8). Six months after the diagnosis, 28 (87.5%) children were still followed up; 21 (75%) were in clinical remission, including 10 (36%) who were in histological remission. After 12 months, 27 patients were still followed up; 21 (78%) achieved clinical remission, including 10 (37%) with histological remission. During follow-up, three patients developed gastroesophageal reflux disease (GERD). There was no difference in body mass index (BMI) Z score between baseline and 12 months follow-up (median - 0.3 vs - 0.3 SD, p = 0.862). CONCLUSIONS: Absence of symptoms does not indicate mucosal healing; therefore, patients should be followed up endoscopically. Additionally, despite restricted diet, nutritional status remains unaffected. Finally, patients with EoE can develop significant GERD even years after the EoE diagnosis.
Authors: Amir F Kagalwalla; Timothy A Sentongo; Sally Ritz; Therese Hess; Suzanne P Nelson; Karan M Emerick; Hector Melin-Aldana; B U K Li Journal: Clin Gastroenterol Hepatol Date: 2006-07-21 Impact factor: 11.382
Authors: Chris A Liacouras; Jonathan M Spergel; Eduardo Ruchelli; Ritu Verma; Maria Mascarenhas; Edisio Semeao; Jonathan Flick; Janice Kelly; Terry Brown-Whitehorn; Petar Mamula; Jonathan E Markowitz Journal: Clin Gastroenterol Hepatol Date: 2005-12 Impact factor: 11.382
Authors: Jonathan M Spergel; Terri F Brown-Whitehorn; Janet L Beausoleil; James Franciosi; Michele Shuker; Ritu Verma; Chris A Liacouras Journal: J Pediatr Gastroenterol Nutr Date: 2009-01 Impact factor: 2.839
Authors: Scott Pentiuk; Phillip E Putnam; Margaret H Collins; Marc E Rothenberg Journal: J Pediatr Gastroenterol Nutr Date: 2009-02 Impact factor: 2.839
Authors: Glenn T Furuta; Chris A Liacouras; Margaret H Collins; Sandeep K Gupta; Chris Justinich; Phil E Putnam; Peter Bonis; Eric Hassall; Alex Straumann; Marc E Rothenberg Journal: Gastroenterology Date: 2007-08-08 Impact factor: 22.682
Authors: Elizabeth T Jensen; Michael D Kappelman; Hannah P Kim; Tamar Ringel-Kulka; Evan S Dellon Journal: J Pediatr Gastroenterol Nutr Date: 2013-07 Impact factor: 2.839
Authors: Christoph Römmele; Robert Mendel; Caroline Barrett; Hans Kiesl; David Rauber; Tobias Rückert; Lisa Kraus; Jakob Heinkele; Christine Dhillon; Bianca Grosser; Friederike Prinz; Julia Wanzl; Carola Fleischmann; Sandra Nagl; Elisabeth Schnoy; Jakob Schlottmann; Evan S Dellon; Helmut Messmann; Christoph Palm; Alanna Ebigbo Journal: Sci Rep Date: 2022-07-01 Impact factor: 4.996